Catamaran (NASDAQ:CTRX) Stock Price, News, Analysis & History

$61.47 0.00 (0.00 %)
(As of 03/23/2018 04:00 PM ET)
Previous Close$61.47
Today's RangeN/A
52-Week Range$39.40 - $61.50
Average Volume2.83 million shs
Market Capitalization$12.78 billion
P/E Ratio37.48
Dividend YieldN/A

About Catamaran (NASDAQ:CTRX)

Catamaran logoCatamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government's Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.

Receive CTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CTRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryHealth Care Services
SectorManaged Health Care - NEC


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio37.4817073170732
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS$1.64
Net IncomeN/A
Net Margins1.66%
Return on Equity6.54%
Return on Assets4.25%


Outstanding Shares208,010,000

Catamaran (NASDAQ:CTRX) Frequently Asked Questions

What is Catamaran's stock symbol?

Catamaran trades on the NASDAQ under the ticker symbol "CTRX."

How were Catamaran's earnings last quarter?

Catamaran Corp (NASDAQ:CTRX) issued its quarterly earnings results on Thursday, February, 26th. The healthcare company reported $0.67 EPS for the quarter, beating analysts' consensus estimates of $0.61 by $0.06. The healthcare company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.57 billion. Catamaran had a return on equity of 6.54% and a net margin of 1.66%. The company's quarterly revenue was up 26.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.56 earnings per share. View Catamaran's Earnings History.

Who are some of Catamaran's key competitors?

Has Catamaran been receiving favorable news coverage?

Headlines about CTRX stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Catamaran earned a media sentiment score of 0.08 on Accern's scale. They also gave headlines about the healthcare company an impact score of 45.98 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Catamaran?

Shares of CTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Catamaran's stock price today?

One share of CTRX stock can currently be purchased for approximately $61.47.

How big of a company is Catamaran?

Catamaran has a market capitalization of $12.78 billion.

How can I contact Catamaran?

Catamaran's mailing address is 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States. The healthcare company can be reached via phone at +1-800-2823232.

MarketBeat Community Rating for Catamaran (CTRX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  170 (Vote Underperform)
Total Votes:  348
MarketBeat's community ratings are surveys of what our community members think about Catamaran and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Catamaran (NASDAQ:CTRX) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Catamaran (NASDAQ:CTRX) Earnings History and Estimates Chart

Earnings by Quarter for Catamaran (NASDAQ:CTRX)

Catamaran (NASDAQ CTRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2015Q1$0.57$0.59$5.73 billion$5.98 billionViewN/AView Earnings Details
2/26/2015Q414$0.61$0.67$5.57 billion$5.74 billionViewN/AView Earnings Details
10/30/2014Q314$0.56$0.58$5.36 billion$5.50 billionViewN/AView Earnings Details
8/1/2014Q214$0.51$0.54$5.01 billion$5.40 billionViewN/AView Earnings Details
5/1/2014Q114$0.44$0.50$4.68 billion$4.90 billionViewN/AView Earnings Details
2/27/2014Q413$0.54$0.56$4.04 billion$4.53 billionViewN/AView Earnings Details
10/31/2013Q3 2013$0.48$0.52$3.71 billion$3.61 billionViewN/AView Earnings Details
8/1/2013Q2 2013$0.44$0.49$3.47 billion$3.38 billionViewN/AView Earnings Details
5/2/2013Q1 2013$0.41$0.42$3.53 billion$3.18 billionViewN/AView Earnings Details
2/28/2013Q4 2012$0.35$0.39$3.33 billion$3.33 billionViewN/AView Earnings Details
11/1/2012Q312$0.24$0.25$3.25 billion$3.15 billionViewN/AView Earnings Details
8/1/2012$0.56$0.49ViewN/AView Earnings Details
5/3/2012$0.51$0.52ViewN/AView Earnings Details
2/23/2012$0.48$0.48ViewN/AView Earnings Details
11/3/2011$0.42$0.44ViewN/AView Earnings Details
8/4/2011$0.38$0.38ViewN/AView Earnings Details
5/5/2011$0.34$0.33ViewN/AView Earnings Details
2/24/2011$0.27$0.26ViewN/AView Earnings Details
11/4/2010Q3 2010$0.13$0.14ViewN/AView Earnings Details
8/5/2010Q2 2010$0.13$0.15ViewN/AView Earnings Details
5/6/2010Q1 2010$0.12$0.13ViewN/AView Earnings Details
3/4/2010Q4 2009$0.10$0.13ViewN/AView Earnings Details
11/5/2009Q3 2009$0.09$0.11ViewN/AView Earnings Details
8/6/2009Q2 2009$0.05$0.13ViewN/AView Earnings Details
5/7/2009Q1 2009$0.04$0.09ViewN/AView Earnings Details
3/5/2009Q4 2008$0.03$0.05ViewN/AView Earnings Details
11/6/2008Q3 2008$0.02$0.04ViewN/AView Earnings Details
8/7/2008Q2 2008$0.03$0.03ViewN/AView Earnings Details
5/8/2008Q1 2008$0.04$0.04ViewN/AView Earnings Details
3/6/2008Q4 2007$0.03$0.05ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Catamaran (NASDAQ:CTRX) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Catamaran (NASDAQ:CTRX)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Catamaran (NASDAQ CTRX)

No insider trades for this company have been tracked by


Catamaran (NASDAQ CTRX) News Headlines

Universal American (UAM) and Catamaran (CTRX) Financial ReviewUniversal American (UAM) and Catamaran (CTRX) Financial Review - January 28 at 7:12 PM
Financial Survey: Catamaran (CTRX) vs. The CompetitionFinancial Survey: Catamaran (CTRX) vs. The Competition - December 19 at 9:32 AM
Analyzing Catamaran (CTRX) and Its PeersAnalyzing Catamaran (CTRX) and Its Peers - December 18 at 1:54 AM
Financial Survey: Catamaran (CTRX) versus Its RivalsFinancial Survey: Catamaran (CTRX) versus Its Rivals - December 15 at 1:34 PM
Head to Head Analysis: Catamaran (CTRX) & Its RivalsHead to Head Analysis: Catamaran (CTRX) & Its Rivals - December 15 at 11:08 AM
Catamaran (CTRX) and Its Rivals Head to Head AnalysisCatamaran (CTRX) and Its Rivals Head to Head Analysis - December 15 at 3:10 AM
Head-To-Head Survey: Catamaran (CTRX) vs. Its CompetitorsHead-To-Head Survey: Catamaran (CTRX) vs. Its Competitors - December 14 at 5:40 PM
Head-To-Head Comparison: Catamaran (CTRX) versus Its CompetitorsHead-To-Head Comparison: Catamaran (CTRX) versus Its Competitors - December 11 at 5:38 AM
Catamaran (CTRX) and Its Competitors Head to Head ComparisonCatamaran (CTRX) and Its Competitors Head to Head Comparison - December 8 at 11:30 PM
Comparing Catamaran (CTRX) and Its CompetitorsComparing Catamaran (CTRX) and Its Competitors - December 4 at 1:28 PM
Catamaran (CTRX) & Its Peers Financial ContrastCatamaran (CTRX) & Its Peers Financial Contrast - December 1 at 11:16 AM
Contrasting Catamaran Corp (CTRX) and The CompetitionContrasting Catamaran Corp (CTRX) and The Competition - November 23 at 9:32 AM
Critical Survey: Catamaran Corp (CTRX) and The CompetitionCritical Survey: Catamaran Corp (CTRX) and The Competition - November 21 at 5:12 AM
The Price of Bitcoin May Be Rising Because of This One FactorThe Price of Bitcoin May Be Rising Because of This One Factor - October 5 at 10:49 AM
As Cyberattacks Rise, This Is Why CEOs Might Want to Prepare for the Worst and Buy BitcoinsAs Cyberattacks Rise, This Is Why CEOs Might Want to Prepare for the Worst and Buy Bitcoins - October 5 at 10:49 AM
Analyzing Anthem (ANTM) and Catamaran Corp (CTRX)Analyzing Anthem (ANTM) and Catamaran Corp (CTRX) - September 4 at 4:06 PM
Catamaran Corp (CTRX) and Cigna Corporation (CI) Head-To-Head SurveyCatamaran Corp (CTRX) and Cigna Corporation (CI) Head-To-Head Survey - September 2 at 4:22 AM
Aetna (AET) & Catamaran Corp (CTRX) Head to Head ReviewAetna (AET) & Catamaran Corp (CTRX) Head to Head Review - September 1 at 4:28 PM
Catamaran Corp (CTRX) vs. Centene Corporation (CNC) Critical ReviewCatamaran Corp (CTRX) vs. Centene Corporation (CNC) Critical Review - August 19 at 10:48 AM
How Aetna and Humana Benefited from UnitedHealths Decisions (UNH, AET)How Aetna and Humana Benefited from UnitedHealth's Decisions (UNH, AET) - April 25 at 12:39 AM
Walgreens Partners With UnitedHealths OptumRx To Manage PrescriptionsWalgreens Partners With UnitedHealth's OptumRx To Manage Prescriptions - March 17 at 8:00 AM
A.M. Best Assigns Ratings to UnitedHealth Group Incorporateds New Senior Unsecured Notes - Business Wire (press release)A.M. Best Assigns Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes - Business Wire (press release) - February 24 at 5:42 PM
Fitch Rates UnitedHealth Groups Planned Issuance A-(EXP) - Business Wire (press release)Fitch Rates UnitedHealth Group's Planned Issuance 'A-(EXP)' - Business Wire (press release) - February 22 at 5:23 PM
UnitedHealth loses $720M on Obamacare plans, but it’s got OptumUnitedHealth loses $720M on Obamacare plans, but it’s got Optum - January 19 at 3:55 PM
UnitedHealths Impressive Growth Leaves Investors Wanting MoreUnitedHealth's Impressive Growth Leaves Investors Wanting More - October 15 at 10:45 AM
UnitedHealth Still Undervalued Despite Big RunupUnitedHealth Still Undervalued Despite Big Runup - July 26 at 11:10 AM
CATAMARAN CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or DispoCATAMARAN CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or Dispo - July 23 at 5:04 PM
UnitedHealth Group Incorporated -- Moodys rates UnitedHealth Groups senior notes A3; negative outlookUnitedHealth Group Incorporated -- Moody's rates UnitedHealth Group's senior notes A3; negative outlook - July 20 at 9:35 AM
UnitedHealth Group (UNH) Earnings Report: Q2 2015 Conference Call TranscriptUnitedHealth Group (UNH) Earnings Report: Q2 2015 Conference Call Transcript - July 16 at 12:04 PM

SEC Filings

Catamaran (NASDAQ:CTRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Catamaran (NASDAQ:CTRX) Income Statement, Balance Sheet and Cash Flow Statement


Catamaran (NASDAQ CTRX) Stock Chart for Saturday, March, 24, 2018

Loading chart…

This page was last updated on 3/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.